Welcome to singular mAb experience
Ready-to-use mAbs
Secondary antibodies : anti – mouse Ig
Secondary antibodies : anti – rat Ig
Secondary antibodies : anti – human Ig
Conjugates : anti-HRP, anti-FITC & Biotin mAbs
IgG isotype controls
Anti-toxins mAbs
Anti-species mAbs
Negative control Ig
Irrelevant Ig : anti-DNP
Anti-human mAbs : cytokines, leucocytes and HIV
Distributors of SynAbs mAbs catalogue
Custom monoclonal antibody development
mAb Starter
Rat Monoclonal Antibodies
High sensitivity anti-Aflatoxin mAbs
Unique mAbs targeting DNA epigenetic modifications
Therapeutic anti-IL34 mAbs
Unique mAbs targeting peptide biomarkers
Singular mAbs for infectious diseases antigens
High affinity mAbs against steroids
anti-drugs mAbs
Singular mAbs for RNA mutations
Guinea pig Monoclonal Antibodies
Contact SynAbs
About SynAbs
SynAbs recent news
A team of mAb experts
Partners for one-stop-shop mAb solution
Innovative Monoclonals for R&D & IVD markets
Rat
Guinea pig
SynAbs attended BioMed congress in Israël!
24. May 2017
tagPlaceholder
Tags:
SynAbs S.A.
Rue Auguste Piccard, 48
I-Tech Incubator 2, Aile Piccard, +1
B-6041 Gosselies
Belgium
Tel +32 71/374.880
